Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinliang Li

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Experimental and Molecular Pathology|June 6, 2022
Retraction notice to "Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1" [Experimental and Molecular Pathology 106 (2019) 131-138]Jinliang Li, Yuxi Qi
Experimental and Molecular Pathology|January 27, 2019
RETRACTED: Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191Yuxi Qi, Jinliang Li
Experimental and Molecular Pathology|July 5, 2022
Retraction notice to "Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191" [Experimental and Molecular Pathology 107 (2019) 23-31]Yuxi Qi, Jinliang Li
Experimental and Molecular Pathology|January 12, 2019
Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1Jinliang Li, Yuxi Qi
International Immunopharmacology|May 9, 2025
Retraction notice to "MiR-92b-3p ameliorates inflammation and autophagy by targeting TRAF3 and suppressing MKK3-p38 pathway in caerulein-induced AR42J cells" [Int. Immunopharmacol. 88 (2020) 106691]Hongzhi Sun, Jiakun Tian, Jinliang Li
BMC Medical Genetics|April 3, 2018
Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese familyJinliang Li, Han Xie, Yuwu Jiang
Journal of Cancer Research and Clinical Oncology|March 28, 2024
Development of a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit: a retrospective analysis based on the MIMIC IV databaseWeikang Li, Jinliang Li, Jinkui Cai
International Immunopharmacology|August 22, 2020
MiR-92b-3p ameliorates inflammation and autophagy by targeting TRAF3 and suppressing MKK3-p38 pathway in caerulein-induced AR42J cellsHongzhi Sun, Jiakun Tian, Jinliang Li
Experimental and Molecular Pathology|January 10, 2020
Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cellsYing He, Zhaoying Yang, Jinliang Li, et al.
ACS Omega|July 1, 2024
Microscopic Structural Evolution of Oxidized Coal Residues with Different Oxidation DegreeLiangzhou Chen, Xuyao Qi, Wei Lu, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Experimental and Molecular Pathology|June 6, 2022
Retraction notice to "Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1" [Experimental and Molecular Pathology 106 (2019) 131-138]Jinliang Li, Yuxi Qi
Experimental and Molecular Pathology|January 27, 2019
RETRACTED: Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191Yuxi Qi, Jinliang Li
Experimental and Molecular Pathology|July 5, 2022
Retraction notice to "Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191" [Experimental and Molecular Pathology 107 (2019) 23-31]Yuxi Qi, Jinliang Li
Experimental and Molecular Pathology|January 12, 2019
Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1Jinliang Li, Yuxi Qi
International Immunopharmacology|May 9, 2025
Retraction notice to "MiR-92b-3p ameliorates inflammation and autophagy by targeting TRAF3 and suppressing MKK3-p38 pathway in caerulein-induced AR42J cells" [Int. Immunopharmacol. 88 (2020) 106691]Hongzhi Sun, Jiakun Tian, Jinliang Li
BMC Medical Genetics|April 3, 2018
Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese familyJinliang Li, Han Xie, Yuwu Jiang
Journal of Cancer Research and Clinical Oncology|March 28, 2024
Development of a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit: a retrospective analysis based on the MIMIC IV databaseWeikang Li, Jinliang Li, Jinkui Cai
International Immunopharmacology|August 22, 2020
MiR-92b-3p ameliorates inflammation and autophagy by targeting TRAF3 and suppressing MKK3-p38 pathway in caerulein-induced AR42J cellsHongzhi Sun, Jiakun Tian, Jinliang Li
Experimental and Molecular Pathology|January 10, 2020
Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cellsYing He, Zhaoying Yang, Jinliang Li, et al.
ACS Omega|July 1, 2024
Microscopic Structural Evolution of Oxidized Coal Residues with Different Oxidation DegreeLiangzhou Chen, Xuyao Qi, Wei Lu, et al.
Pageof 22